Study Stopped
The PI couldn't participate to the study finally
Withings Devices Follow-up Study - Hypertension
1 other identifier
observational
N/A
1 country
1
Brief Summary
The primary objective is to evaluate the accuracy to predict uncontrolled hypertension with Withings device data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 12, 2024
CompletedFirst Posted
Study publicly available on registry
November 18, 2024
CompletedFebruary 19, 2026
February 1, 2026
Same day
November 12, 2024
February 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prediction of uncontrolled hypertension
Correlation between uncontrolled hypertension, Withings data, and survey answers
2 years
Secondary Outcomes (2)
Correlation between Framingham risk score and EQ-5D-5L answers and Withings data
2 years
Number of Questionnaires answers per participant
2 years
Study Arms (1)
Withings device users
Active Withings device users having at least 2 years of device data
Interventions
Users who consent to the study will receive a questionnaire every 3 months
Eligibility Criteria
The population meeting the inclusion criteria will all live in the US, regular and active users of one or several WITHINGS devices, who agreed to receive notifications from Withings Clinical Operations department, and who have previously acquired a WITHINGS device. They will receive a notification through their WITHINGS application, offering them the opportunity to participate in the study. In case of a positive answer, the user will be redirected to the study information sheet.
You may qualify if:
- Male or female who are 21 years of age or older,
- Participant living in the United States,
- Participant with data recorded in WITHINGS database,
- Active WITHINGS device users having at least 2 years of data,
- Subject able to read, understand, and provide written informed consent,
- Subject willing and able to participate in the study procedures as described in the consent form,
- Subject able to communicate effectively with and willing to follow instructions from the study staff.
You may not qualify if:
- Minors under 21 years old,
- Subject who refused to participate in the study,
- Subject who did not reply to the questionnaire,
- Subject who objected to the processing of his or her data after the start of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Withingslead
Study Sites (1)
Yale University Medical School, Department of Neurology
New Haven, Connecticut, 06150, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
de Havenon, MD
Yale University School of Medicine, Dept of Neurology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2024
First Posted
November 18, 2024
Study Start
November 1, 2024
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
February 19, 2026
Record last verified: 2026-02